Equities

American Cannabis Company Inc

NW8N:BER

American Cannabis Company Inc

Actions
  • Price (EUR)0.0591
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 07 2022 07:38 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year American Cannabis Company Inc's revenues fell -86.83% from 18.81m to 2.48m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 633.19k to a larger loss of 3.66m.
Gross margin43.13%
Net profit margin-164.89%
Operating margin-175.25%
Return on assets-94.64%
Return on equity-493.34%
Return on investment-246.89%
More ▼

Cash flow in USDView more

In 2023, cash reserves at American Cannabis Company Inc fell by 96.46k. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 42.79k for operations while cash used for investing totalled 39.10k.
Cash flow per share-0.0279
Price/Cash flow per share--
Book value per share-0.0007
Tangible book value per share-0.0059
More ▼

Balance sheet in USDView more

American Cannabis Company Inc has a Debt to Total Capital ratio of 123.62%, a higher figure than the previous year's 22.73%.
Current ratio0.3796
Quick ratio0.0686
Total debt/total equity--
Total debt/total capital1.24
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.